The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProPhotonix Announces Cobra Cure (TM)FX UV LED

9 Sep 2015 07:00

RNS Number : 4677Y
ProPhotonix Limited
09 September 2015
 

 

September 9, 2015

 

ProPhotonix Limited

("ProPhotonix" or "the Company")

ProPhotonix introduces COBRA Cure™ FX UV LED Lamp with IntelliSenseTM Smart Sensing Technology

Stackable Design, Field-Replaceable Window, Multiple Optical Output Options, Innovative sensing software

 

ProPhotonix Limited (London Stock Exchange - AIM: PPIX and, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, today announces the launch of the COBRA Cure FX, a UV LED lamp ideally suited to a range of ultra violet ("UV") curing applications. COBRA Cure FX is a patent pending, compact, fan-cooled UV LED lamp in a stackable form factor that produces a uniform line with a peak irradiance of 4 W/cm2 and peak energy density (dose) of 3 J/cm2. COBRA Cure FX is offered in numerous optical configurations and is available in a range of wavelengths including 365nm, 385nm 395nm and 405nm. Multiple wavelength versions are also available.

LED illumination offers significant benefits versus traditional UV lamps including longer illuminator lifetimes, high stability light output, precise control, thermal management, ozone-free, heavy metal free, and lower total cost of ownership.

 

The COBRA Cure FX unique design includes a field-replaceable exit window. In certain operating environments, materials can build-up over time on the outer surface of the window which reduces the intensity of the light causing a degradation of system performance. Without this unique design, the operator must manually clean the emitter window which causes machine down time but also causes abrasion damage to the window thus reducing the light's effectiveness during operation. The field-replaceable window allows fast and efficient changes by non-technical personnel. This innovative patent pending design is easy to use, requires no special tools for window replacement, and ensures that the window is secure during operation, thus minimizing system downtime.

COBRA Cure FX also incorporates IntelliSense, a patent pending new smart sensing technology which provides precise output control, operational intelligence and "Plug & Play" integration for end users. Sensing features include: real-time thermal monitoring, a necessity ensuring proper system operation; intensity monitoring, providing operating irradiance and efficiency data; lifetime prediction of the lamp, reliability and longevity estimates; and numerous health & safety features. IntelliSense is the state of the art sensing capability in illumination.

Commenting on the COBRA Cure FX launch, Tim Losik, CEO and President of ProPhotonix, said:

"Over the past two years we have assessed various markets and product features and have developed a product strategy focusing on large markets complemented by our design capabilities. To this end, we are concentrating our engineering talents in a couple of specific market areas which we believe are poised for fast market expansion. One of these is the ultra violet LED and laser market, addressing various applications including: printing, curing, 3D printing, bio-luminescence, medical microscopy, and other applications. Market research shows that the 2014 market size for UV LED applications was approximately $90 million with projected growth to $500 million by 2019, a compound average annual growth rate of nearly 40%.

"This product redefines the capabilities of the world's best UV LED lamps by increasing the operational capabilities and improving customer ease of use. As this product line develops, we intend to introduce more exciting enhancements and capabilities for users. To protect our intellectual property rights within this product, United States Patent Applications have recently been filed covering several of the unique features of the product design including the capabilities of IntelliSense. We will continue to file patent applications, where appropriate, to protect our expanding intellectual property portfolio."

 

For more information about ProPhotonix' COBRA Cure FX, visit http://www.prophotonix.com/products/UV-Solutions/

 

Enquiries:

ProPhotonix Limited

Tim Losik

 

sales@prophotonix.com

 

Tel: +1 603 893 8778

 

N+1 Singer

Ben Wright/ Richard Salmond

Tel: +44 (0) 207 496 3000

Nominated Adviser and Broker

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio (formerly Opnext), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, ultra violet applications, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

 

Cautionary Statement 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

 

 

 

 

 

 

 

 

 

 

#######

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADVLFBEKFEBBD
Date   Source Headline
16th Dec 20217:00 amRNSSale of ProPhotonix and cancelation of AIM Listing
17th Nov 20217:00 amRNSNotice of GM
11th Nov 202111:05 amRNSSecond Price Monitoring Extn
11th Nov 202111:00 amRNSPrice Monitoring Extension
11th Nov 20217:00 amRNSProPhotonix Announces Merger Agreement
2nd Nov 20217:00 amRNSProPhotonix Extends COBRA HyperSpec range
14th Sep 20217:00 amRNSProPhotonix announces the new UV COBRA Cure FX4
8th Sep 20217:00 amRNS2021 Half-year Report
9th Jun 20217:00 amRNSPosting of Annual Report and Accounts
2nd Jun 20217:00 amRNSNew Wavelengths added to UVC LED System
25th Mar 20217:00 amRNSResults for the year ended December 31, 2020
26th Jan 20217:00 amRNSNew Hyperspectral COBRA MultiSpec LED Line Light
16th Nov 20202:05 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSAdmission of Shares
10th Nov 20207:00 amRNSProPhotonix introduces 265nm UVC LED Lamp
9th Nov 20204:45 pmRNSResult of AGM and Director / PDMR Shareholdings
9th Oct 20207:00 amRNSPOSTING OF NOTICE OF ANNUAL GENERAL MEETING
8th Oct 20207:00 amRNSNew RGB-IR & RGB-White COBRA MultiSpec Line Lights
7th Oct 20203:07 pmRNSHolding(s) in Company
10th Sep 20207:00 amRNSINTERIM RESULTS FOR HALF YEAR ENDED JUNE 30, 2020
3rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
2nd Sep 20207:00 amRNSPROdigii Digital Lasers Range - 5 New Wavelengths
27th Aug 20207:00 amRNSRESULTS FOR THE YEAR ENDED DECEMBER 31, 2019
25th Aug 20201:47 pmRNSNOTICE OF EXTENSION OF RIGHTS PLAN
24th Jul 20207:00 amRNSHolding(s) in Company
16th Jul 20207:00 amRNSChange of Adviser and Director Disclosures
29th Jun 20207:00 amRNSCustom LED Backlight wins VSD Innovators Award
23rd Jun 20207:00 amRNSAccounts Reporting Extension & Trading Update
30th Apr 20207:00 amRNSDirectorate Change
9th Apr 20207:00 amRNSCOVID – 19 and Trading Update
19th Mar 20207:00 amRNS3 Year Framework Product Supply & IP Agreement
16th Mar 20207:00 amRNSProPhotonix - UV LED Water Disinfection
16th Jan 20207:00 amRNSTrading Update 2019
26th Nov 20197:00 amRNSHolding(s) in Company
10th Oct 20197:00 amRNS5-Year Master Purchase Agreement - Fortune 50 CGLM
12th Sep 20197:00 amRNSProPhotonix to Exhibit UV Lamps at Labelexpo 2019
6th Sep 20197:00 amRNSProPhotonix issues Half-year Report
3rd Sep 20197:00 amRNSNew High-Powered Red Laser Diode from Ushio
31st May 201911:59 amRNSProPhotonix Notification of Major Holdings
31st May 201911:58 amRNSProPhotonix Notification of Major Holdings
24th May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
23rd May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
17th May 20197:00 amRNSProPhotonix Announces Trading Update
16th May 20195:58 pmRNSPPIX Announces AGM Results and PDMR Shareholdings
16th May 20197:00 amRNSPPIX Offers New COBRA Cure Mini UV Curing System
9th Apr 20197:00 amRNSProPhotonix Honored by Vision Systems Design 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.